Full Name
Shanmugam M.K.
Variants
Shanmugam M.K.
 
Main Affiliation
 
 
Email
muthu@nus.edu.sg
 
Researcher ID
 

Publications

Results 1-20 of 23 (Search time: 0.02 seconds).

Issue DateTitleAuthor(s)
11-Jan-2016Ageing and the telomere connection: An intimate relationship with inflammationZhang, Jingwen; Rane, Grishma ; Dai, Xiaoyun; Shanmugam, Muthu K ; Arfuso, Frank; Samy, Ramar Perumal ; Lai, Mitchell Kim Peng ; Kappei, Dennis ; Kumar, Alan Prem ; Sethi, Gautam 
22020Anti-proliferative activity and characterization data on oxadiazole derivativesDukanya; Shanmugam, Muthu K. ; Rangappa, S.; Metri, P.K.; Mohan, S.; Basappa; Rangappa, K.S.
32016ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and C-Myc to reduce breast cancer proliferationYuan, Y ; Anbalagan, D; Lee, L.H; Samy, R.P ; Shanmugam, M.K ; Kumar, A.P ; Sethi, G ; Lobie, P.E ; Lim, L.H.K 
42018Celastrol attenuates the invasion and migration and augments the anticancer effects of bortezomib in a xenograft mouse model of multiple myelomaShanmugam, M.K ; Ahn, K.S; Lee, J.H; Kannaiyan, R; Mustafa, N ; Manu, K.A ; Siveen, K.S ; Sethi, G ; Chng, W.J ; Kumar, A.P 
52018Evidence for the involvement of the master transcription factor NF-κB in cancer initiation and progressionPuar, Y.R; Shanmugam, M.K ; Fan, L ; Arfuso, F; Sethi, G ; Tergaonkar, V 
62015Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersLi F. ; Shanmugam M.K. ; Siveen K.S. ; Wang F. ; Ong T.H.; Loo S.Y. ; Swamy M.M.M.; Mandal S.; Kumar A.P. ; Goh B.C. ; Kundu T.; Ahn K.S.; Wang L.Z. ; Hui K.M. ; Sethi G. 
72020Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cellsSomu, C.; Mohan, C.D.; Ambekar, S.; Dukanya; Rangappa, S.; Baburajeev, C.P.; Sukhorukov, A.; Mishra, S. ; Shanmugam, M.K. ; Chinnathambi, A.; Awad Alahmadi, T.; Alharbi, S.A.; Basappa; Rangappa, K.S.
82015Inhibition of p300 Lysine Acetyltransferase activity by Luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse modelSelvi, R.B; Swaminathan, A; Chatterjee, S; Shanmugam, M.K ; Li, F ; Ramakrishnan, G.B; Siveen, K.S ; Chinnathambi, A; Emam Zayed, M; Alharbi, S.A; Basha, J; Bhat, A; Vasudevan, M; Dharmarajan, A; Sethi, G ; Kundu, T.K
92018N-substituted pyrido-1,4-Oxazin-3-ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-?B signaling pathwayMohan, C.D; Bharathkumar, H; Dukanya, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, S; Shanmugam, M.K ; Chinnathambi, A; Alharbi, S.A; Alahmadi, T.A; Bhattacharjee, A; Lobie, P.E ; Deivasigamani, A; Hui, K.M; Sethi, G ; Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Bangalore, India, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, K.S; Kumar, A.P 
102015Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patientsDai X.; Ahn K.S.; Kim C.; Siveen K.S. ; Ong T.H.; Shanmugam M.K. ; Li F.; Shi J. ; ALAN PREM KUMAR ; Wang L.Z. ; Goh B.C. ; Magae J.; Hui K.M.; Sethi G. 
112018Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-κB in hepatocellular carcinoma cellsMohan, C.D; Anilkumar, N.C; Rangappa, S; Shanmugam, M.K ; Mishra, S ; Chinnathambi, A; Alharbi, S.A; Bhattacharjee, A; Sethi, G ; Kumar, A.P ; Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Bangalore, India, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, K.S
122020Novel 1,3,4-oxadiazole targets STAT3 signaling to induce antitumor effect in lung cancerMalojirao, V.H.; Girimanchanaika, S.S.; Shanmugam, Muthu K. ; Sherapura, A.; Dukanya; Metri, P.K.; Vigneshwaran, V.; Chinnathambi, A.; Alharbi, S.A.; Rangappa, S.; Mohan, C.D.; Basappa; Prabhakar, B.T.; Rangappa, K.S.
132019Oxymatrine attenuates tumor growth and deactivates STAT5 signaling in a lung cancer xenograft modelJung, Y.Y; Shanmugam, M.K ; Narula, A.S; Kim, C; Lee, J.H; Namjoshi, O.A; Blough, B.E; Sethi, G ; Ahn, K.S
14Nov-2017PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.Chen, Luxi ; Yuan, Yi; Kar, Shreya; Kanchi, Madhu M ; Arora, Suruchi; Kim, Ji E; Koh, Pei F ; Yousef, Einas; Samy, Ramar P ; Shanmugam, Muthu K ; Tuan Z ; Shin, Sung W; Arfuso, Frank; Shen, Han M ; Yang, Henry; Goh, Boon C ; Park, Joo I; Gaboury, Louis; Lobie, Peter E ; Sethi, Gautam ; Lim, Lina HK ; Kumar, Alan P 
152018Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical reviewSethi, G ; Shanmugam, M.K ; Warrier, S; Merarchi, M; Arfuso, F; Kumar, A.P ; Bishayee, A
162018Role of novel histone modifications in cancerShanmugam, M.K ; Arfuso, F; Arumugam, S; Chinnathambi, A; Jinsong, B ; Warrier, S; Wang, L.Z ; Kumar, A.P ; Ahn, K.S; Sethi, G ; Lakshmanan, M
172018Role of RNF20 in cancer development and progression – a comprehensive reviewSethi, G ; Shanmugam, M.K ; Arfuso, F; Kumar, A.P 
182020Sphingosine 1-phosphate receptor 2 induces otoprotective responses to cisplatin treatmentWang, W. ; Shanmugam, M.K. ; Xiang, P. ; Yam, T.Y.A. ; Kumar, V. ; Chew, W.S. ; Chang, J.K.; Ali, M.Z.B. ; Reolo, M.J.Y. ; Peh, Y.X. ; Karim, S.N.B.A. ; Tan, A.Y.Y. ; Sanda, T. ; Sethi, G. ; Herr, D.R. 
192017SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinomaSethi, G ; Shanmugam, M.K ; Kumar, A.P 
202018The application of embelin for cancer prevention and therapyKo, J.-H; Lee, S.-G; Yang, W.M; Um, J.-Y; Sethi, G ; Mishra, S ; Shanmugam, M.K ; Ahn, K.S